CureVac N.V. (FRA:5CV)
4.692
+0.002 (0.04%)
Aug 14, 2025, 5:48 PM CET
CureVac Employees
As of December 31, 2024, CureVac had 983 total employees, including 825 full-time and 158 part-time employees. The number of employees decreased by 189 or -16.13% compared to the previous year.
Employees
983
Change (1Y)
-189
Growth (1Y)
-16.13%
Revenue / Employee
€579,314
Profits / Employee
€199,840
Market Cap
1.06B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 983 | -189 | -16.13% |
Dec 31, 2023 | 1,172 | 123 | 11.73% |
Dec 31, 2022 | 1,049 | 165 | 18.67% |
Dec 31, 2021 | 884 | 330 | 59.57% |
Dec 31, 2020 | 554 | 100 | 22.03% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Siemens Healthineers AG | 72,000 |
Merck KGaA | 59,020 |
Bayer Aktiengesellschaft | 91,864 |
Fresenius SE & Co. KGaA | 176,486 |
Fresenius Medical Care AG | 111,513 |
Sartorius Aktiengesellschaft | 13,528 |
Fielmann Group AG | 24,363 |
Carl Zeiss Meditec AG | 5,730 |
CureVac News
- 6 days ago - GSK, CureVac to receive $740M as COVID vaccine patent dispute with Pfizer, BioNTech settled - Seeking Alpha
- 6 days ago - GSK to be paid up to £370 million after patent row settles in US - Evening Standard
- 6 days ago - CureVac settles patent dispute litigation with Pfizer and BioNTech - Reuters
- 6 days ago - CureVac Resolves Patent Dispute with Pfizer/BioNTech! - Wallstreet:Online
- 6 days ago - EQS-News: CureVac Announces Resolution of Patent Litigation with Pfizer/BioNTech - Wallstreet:Online
- 7 weeks ago - CureVac Announces Voting Results of General Meeting - Accesswire
- 7 weeks ago - CureVac's General Meeting: Key Voting Results Revealed! - Wallstreet:Online
- 7 weeks ago - EQS-News: CureVac Announces Voting Results of General Meeting - Wallstreet:Online